Tag: 贵族宝贝Gisselle

read more

first_img The MD Anderson Proton Therapy Center expansion is expected to be completed in 2023. Rendering courtesy of Stantec. Related Content News | Radiation Therapy | August 15, 2019 First Patient Enrolled in World’s Largest Brain Cancer Clinical Trial Henry Ford Cancer Institute is first-in-the-world to enroll a glioblastoma patient in the GBM AGILE Trial (Adaptive… read more September 27, 2011 – Continual visual verification that a tumor is being accurately targeted during a radiotherapy treatment is now possible with recent enhancements to the TrueBeam system. This capability, called intrafraction motion review (IMR), is among the innovations that Varian Medical will showcase at this year’s annual meeting of the American Society for Radiation Oncology (ASTRO) in Miami Beach next week.With intrafraction motion review, clinicians can use the imager on a TrueBeam system to continually monitor tumor location during treatment to ensure that the tumor hasn’t moved out of range due to changes in the patient’s breathing pattern.”By introducing intrafraction treatment imaging and combining it with the millisecond response time of the TrueBeam machine, we can minimize the effects of changes in tumor motion during treatment,” said Chris Toth, senior director of marketing for the company.Varian will exhibit the company’s full spectrum of products for planning and delivering image-guided radiotherapy and proton therapy, with a special emphasis on recent enhancements to its devices and software products, including:A motion management interface for the Trilogy machine that enables integration with the Calypso system for tracking the prostate gland during treatment, for greater targeting accuracy.A new user-centric design for the Aria oncology information system, with more personalization to the user, easy-to-follow task-driven workflows, greater automation and a single clinical management system that accesses both Aria and Varian’s Eclipse treatment planning system from a single unified dashboard.A new Aria iPad application that allows clinicians greater mobility.New tools for using different types of images, including magnetic resonance (MR) images, to adapt a patient’s treatment plan if there have been anatomical changes such as tumor shrinkage or weight loss during a multiple-week course of treatment.A new version of Varian’s BrachyVision software for planning brachytherapy treatments that is now fully integrated with the Aria oncology information system (OIS) for seamless management of patient data information.A specially-designed treatment couch attachment that enables breast cancer treatments with the patient in the prone position to help minimize radiation exposure to heart and lung tissue and facilitates the use of RapidArc radiotherapy in the treatment of some breast cancer cases.Several products in the development pipeline which have been submitted to the U.S Food and Drug Administration (FDA) for review will also be on display, including:Higher dose delivery rates on the company’s Trilogy and Clinac iX machines, for delivering high dose treatments more quickly to shorten treatment times and increase clinical efficiency.New contouring tools that expedite treatment planning by using “smart” software to automatically identify and outline organs and other structures within diagnostic images and that enable clinicians to draw on a library of pre-contoured images by expert radiation oncologists and use these as a starting point for creating new treatment plans.”Each of these innovations was designed to enable clinicians to make optimal treatment choices for their patients. By facilitating accurate, efficient treatments, these advances in Varian technology can help clinicians tackle even the most complex cases with confidence,” said Toth. “Varian is committed to providing cancer treatment professionals with the best possible tools and devices for helping patients fight cancer.”For more information: www.varian.com FacebookTwitterLinkedInPrint分享 News | Patient Positioning Radiation Therapy | August 15, 2019 Mevion and C-RAD Release Integration for Improved Proton Therapy Treatment Quality Mevion Medical Systems and C-RAD announced the integration between the C-RAD Catalyst PT and the Mevion S250i proton… read more Catalyst PT image courtesy of C-RAD News | Proton Therapy | August 06, 2019 IBA Signs Contract to Install Proton Therapy Center in Kansas IBA (Ion Beam Applications S.A.) recently signed a contract and received the first payment for a Proteus One solution… read more News | Radiation Therapy | August 02, 2019 Varian Showcases Cancer Care Systems and Software at AAPM 2019 Varian showcased systems and software from its cancer care portfolio, including the Identify Guidance System, at the… read more News | Brachytherapy Systems | August 14, 2019 Efficacy of Isoray’s Cesium Blu Showcased in Recent Studies August 14, 2019 — Isoray announced a trio of studies recently reported at scientific meetings and published in medica read more Feature | August 05, 2019 | Dave Fornell, Editor Most Popular Radiology and Radiotherapy Topics in July 2019 August 5, 2019 — Here is the list of the most popular content on the Imaging Technology New (ITN) magazine website fr read more News | Proton Therapy | August 08, 2019 MD Anderson to Expand Proton Therapy Center The University of Texas MD Anderson Cancer Center unveiled plans to expand its Proton Therapy Center during a… read more News | Patient Positioning Radiation Therapy | August 07, 2019 Qfix kVue One Proton Couch Top Validated by Mevion Medical Systems Qfix and Mevion Medical Systems announced that a special version of the kVue One Proton couch top is now both validated… read more News | Radiation Oncology | July 31, 2019 Laura Dawson, M.D., FASTRO, Chosen as ASTRO President-elect The members of the American Society for Radiation Oncology (ASTRO) elected four new officers to ASTRO’s Board of… read more Technology | September 27, 2011 Varian Enhances TrueBeam, Introduces New Innovations at ASTRO Following radiation, the bone marrow shows nearly complete loss of blood cells in mice (left). Mice treated with the PTP-sigma inhibitor displayed rapid recovery of blood cells (purple, right). Credit: UCLA Broad Stem Cell Research Center/Nature Communications News | Radiation Therapy | August 16, 2019 Drug Accelerates Blood System’s Recovery After Radiation, Chemotherapy A drug developed by UCLA physician-scientists and chemists speeds up the regeneration of mouse and human blood stem… read more The top piece of content in July was a video interview explaining how Princess Margaret Cancer Center is using machine learning to create automated treatment plans. This was a hot topic at the American Association of Physicists in Medicine (AAPM) 2019 meeting in July. last_img read more